Geovax Stock Analysis

GOVX -  USA Stock  

USD 2.43  0.21  7.95%

The big decline in price over the last few months for Geovax Labsmay raise some interest from investors. The stock closed today at a share price of 2.43 on very low momentum in trading volume. The company directors and management failed to add value to investors and positioning the firm supply of money to exploit market volatility in December. However, diversifying your holdings with Geovax Labs or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 5.83. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Geovax Labs partners.
Please check Risk vs Return Analysis.

Geovax Stock Analysis 

 
Refresh
The Geovax Labs stock analysis report makes it easy to digest most publicly released information about Geovax Labs and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Geovax Stock analysis module also helps to analyze the Geovax Labs price relationship with some important fundamental indicators such as market cap and management efficiency.

Geovax Stock Analysis Notes

The company has price-to-book (P/B) ratio of 0.98. Some equities with similar Price to Book (P/B) outperform the market in the long run. Geovax Labs recorded a loss per share of 1.13. The entity had not issued any dividends in recent years. The firm had 1-20 split on the 25th of September 2020. GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. GeoVax Labs, Inc. was incorporated in 2001 and is based in Smyrna, Georgia. Geovax Labs operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 7 people. To learn more about Geovax Labs call Robert McNally at 678 384 7220 or check out https://www.geovax.com.

Geovax Labs Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Geovax Labs' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Geovax Labs or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Geovax Labs generated a negative expected return over the last 90 days
Geovax Labs has high historical volatility and very poor performance
The company reported the previous year's revenue of 472.16 K. Net Loss for the year was (6.16 M) with loss before overhead, payroll, taxes, and interest of (620.8 K).
Geovax Labs currently holds about 18.11 M in cash with (6.06 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.84, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Geovax Labs has a poor financial position based on the latest SEC disclosures
Latest headline from www.marketscreener.com: GeoVax Announces Closing of 10 Million Private Placement - marketscreener.com

Geovax Labs Upcoming and Recent Events

Earnings reports are used by Geovax Labs to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Geovax Labs previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report22nd of March 2022
Next Fiscal Quarter End31st of December 2021

Geovax Labs SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Geovax Labs prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Geovax Labs investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Geovax Labs specific information freely available to individual and institutional investors to make a timely investment decision.
4th of January 2022
Financial Statements and Exhibits. Regulation FD Disclosure. Unclassified Corporate Event
View
15th of December 2021
Financial Statements and Exhibits. Regulation FD Disclosure
View
12th of November 2021
Financial Statements and Exhibits. Regulation FD Disclosure. Results of Operations and Financial Condition
View
10th of November 2021
Financial Statements and Exhibits. Regulation FD Disclosure. Entry into a Material Definitive Agreement
View
30th of September 2021
Financial Statements and Exhibits. Regulation FD Disclosure
View
29th of September 2021
Financial Statements and Exhibits. Regulation FD Disclosure. Unregistered Sales of Equity Securities. Entry into a Material Definitive Agreement
View
20th of August 2021
Financial Statements and Exhibits. Other Events
View
11th of August 2021
Financial Statements and Exhibits. Submission of Matters to a Vote of Security Holders. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Results of Operations and Financial Condition
View

Geovax Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Geovax Labs is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Geovax Labs backward and forwards among themselves. Geovax Labs' institutional investor refers to the entity that pools money to purchase Geovax Labs' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Vanguard Group IncCommon Shares259.2 K1.1 M
Geode Capital Management LlcCommon Shares59.1 K255 K
Gsa Capital Partners LlpCommon Shares41.1 K178 K
Cvi Holdings LlcWarrants72 K100 K
State Street CorpCommon Shares21.7 K94 K
Blackrock IncCommon Shares17.9 K78 K
Welch Forbes LlcCommon Shares17 K73 K
Squarepoint Ops LlcCommon Shares11.7 K51 K
Note, although Geovax Labs' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Geovax Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 17.68 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Geovax Labs's market, we take the total number of its shares issued and multiply it by Geovax Labs's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Geovax Profitablity

Geovax Labs' profitability indicators refer to fundamental financial ratios that showcase Geovax Labs' ability to generate income relative to its revenue or operating costs. If, let's say, Geovax Labs is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Geovax Labs' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Geovax Labs' profitability requires more research than a typical breakdown of Geovax Labs' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2022
Return on Average Assets(0.44) (0.48) 
Return on Average Equity(0.82) (0.84) 
Return on Invested Capital 2.80  3.03 
Return on Sales(1.39) (1.50) 

Management Efficiency

The entity has return on total asset (ROA) of (26.33) % which means that it has lost $26.33 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (42.78) %, meaning that it created substantial loss on money invested by shareholders. Geovax Labs management efficiency ratios could be used to measure how well geovax labs manages its routine affairs as well as how well it operates its assets and liabilities. Return on Invested Capital is likely to rise to 3.03 in 2022, whereas Return on Average Assets are likely to drop (0.48)  in 2022. Geovax Labs Total Assets are fairly stable at the moment as compared to the past year. Geovax Labs reported Total Assets of 11.95 Million in 2021. Current Assets is likely to rise to about 12.7 M in 2022, whereas Assets Non Current are likely to drop slightly above 117.9 K in 2022.
Last ReportedProjected for 2022
Book Value per Share 6.22  6.38 
Enterprise Value over EBIT(1.15) (1.24) 
Enterprise Value over EBITDA(0.61) (0.66) 
Price to Book Value 1.21  1.24 
Tangible Assets Book Value per Share 6.76  6.94 
Enterprise Value1.3 M1.4 M
Tangible Asset Value12 M12.9 M

Technical Drivers

As of the 23rd of January, Geovax Labs retains the risk adjusted performance of (0.08), and Market Risk Adjusted Performance of (3.80). Geovax Labs technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Geovax Labs, which can be compared to its competitors. Please check out Geovax Labs standard deviation, value at risk, as well as the relationship between the Value At Risk and kurtosis to decide if Geovax Labs is priced fairly, providing market reflects its last-minute price of 2.43 per share. Please also validate Geovax Labs total risk alpha, which is currently at (0.21) to confirm the company can sustain itself at a future point.

Geovax Labs Price Movement Analysis

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Exponential Moving Average is calculated by weighting recent values of Geovax Labs more heavily than older values. View also all equity analysis or get more info about exponential moving average overlap studies indicator.

Geovax Labs Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Geovax Labs insiders, such as employees or executives, is commonly permitted as long as it does not rely on Geovax Labs' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Geovax Labs insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Geovax Labs Technical and Predictive Indicators

Geovax Labs Forecast Models

Geovax Labs time-series forecasting models is one of many Geovax Labs' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Geovax Labs' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Geovax Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Geovax Labs stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Geovax shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Geovax Labs. By using and applying Geovax Stock analysis, traders can create a robust methodology for identifying Geovax entry and exit points for their positions.
Last ReportedProjected for 2022
EBITDA Margin(1.38) (1.49) 
Gross Margin 0.90  0.89 
Profit Margin(1.46) (1.57) 
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. GeoVax Labs, Inc. was incorporated in 2001 and is based in Smyrna, Georgia. Geovax Labs operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 7 people.

Current Geovax Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Geovax analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Geovax analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
10.0Strong Buy1Odds
Geovax Labs current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Geovax analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Geovax stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Geovax Labs, talking to its executives and customers, or listening to Geovax conference calls.
Geovax Analyst Advice Details

Geovax Stock Analysis Indicators

Geovax Labs stock analysis indicators help investors evaluate how Geovax Labs stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Geovax Labs shares will generate the highest return on investment. By understating and applying Geovax Labs stock analysis, traders can identify Geovax Labs position entry and exit signals to maximize returns.
Quick Ratio53.95
Fifty Two Week Low2.6400
Revenue Growth-92.70%
Shares Short Prior Month199.38k
Average Daily Volume Last 10 Day143.86k
Average Daily Volume In Three Month1.01M
Shares Percent Shares Out3.95%
Short Percent Of Float4.14%
Forward Price Earnings-2.18
Float Shares6.13M
Fifty Two Week High8.7100
Enterprise Value To Ebitda-0.75
Fifty Day Average3.8435
Two Hundred Day Average4.5387
Enterprise Value To Revenue10.04
Please check Risk vs Return Analysis. Note that the Geovax Labs information on this page should be used as a complementary analysis to other Geovax Labs' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Geovax Stock analysis

When running Geovax Labs price analysis, check to measure Geovax Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Geovax Labs is operating at the current time. Most of Geovax Labs' value examination focuses on studying past and present price action to predict the probability of Geovax Labs' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Geovax Labs' price. Additionally, you may evaluate how the addition of Geovax Labs to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Is Geovax Labs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Geovax Labs. If investors know Geovax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Geovax Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Geovax Labs is measured differently than its book value, which is the value of Geovax that is recorded on the company's balance sheet. Investors also form their own opinion of Geovax Labs' value that differs from its market value or its book value, called intrinsic value, which is Geovax Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Geovax Labs' market value can be influenced by many factors that don't directly affect Geovax Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Geovax Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine Geovax Labs value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Geovax Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.